NASDAQ: EOLS $200 Million Small-Cap. Health Care Sector. Drug Manufacturers Industry. 5 Year Return 50%. 1 Year Return 43%. 2021 YTD Return 81%. Since Earnings 87%.
The 52 Week Low is $2.85 set on Thu, Oct 29, 2020.
The 52 Week High is $11.41 set on Tue, Jan 21, 2020.
The All-Time High is $38.74 set on Wed, Jun 6, 2018.
Earnings Per Share
Price To Earnings Ratio
Dividend Yield
Dividend Rate
Ex-Dividend Date
Dividend Payment Date
Dividend Frequency
Dividend History
Evolus Inc trades on the NASDAQ. EOLS's market cap is 200.00 Million.
Evolus Inc is engaged in providing physicians and their patients with expanded choices in medical aesthetic treatments and procedures. Its product candidate is an injectable formulation of a 900 kDa Botulinum toxin Type A complex. It has also completed the development program for DWP-450 for the treatment of moderate to severe glabellar lines.
For Starters
Track your portfolio and more.
